Karyopharm Therapeutics Inc.
KPTI
$1.62
-$0.08-4.44%
NASDAQ
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Net Income | -67.02M | -22.39M | -102.20M | -33.13M | -37.25M |
| Total Depreciation and Amortization | -3.00K | 12.00K | 19.00K | 121.00K | 78.00K |
| Total Amortization of Deferred Charges | 2.56M | 2.36M | 2.45M | 2.81M | 2.72M |
| Total Other Non-Cash Items | 38.27M | -6.56M | 82.41M | 10.09M | 5.71M |
| Change in Net Operating Assets | 1.27M | 3.85M | 5.50M | 14.25M | 10.05M |
| Cash from Operations | -24.93M | -22.73M | -11.83M | -5.86M | -18.70M |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -10.04M | 3.20M | 5.00M | 4.81M | 18.29M |
| Cash from Investing | -10.04M | 3.20M | 5.00M | 4.81M | 18.29M |
| Total Debt Issued | -- | -- | 27.25M | -- | -- |
| Total Debt Repaid | -- | -- | -250.00K | -- | -- |
| Issuance of Common Stock | 574.00K | 50.23M | 9.16M | 0.00 | 356.00K |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -1.47M | -431.00K | -6.46M | -- | -- |
| Cash from Financing | -898.00K | 49.80M | 29.69M | 0.00 | 356.00K |
| Foreign Exchange rate Adjustments | -4.00K | 2.00K | 5.00K | 2.00K | 8.00K |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -35.87M | 30.28M | 22.87M | -1.05M | -48.00K |